Skip to navigation Skip to content

Fibrodysplasia ossificans progressiva (FOP) Program in Pharmaceutical Benefits Scheme (PBS) 012-25080655

Expand/Collapse all sectionsExpand all



This document outlines details of PBS-subsidised palovarotene for patients with fibrodysplasia ossificans progressiva (FOP).

For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.

Fibrodysplasia ossificans progressiva (FOP) quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Chronic treatment

PB387 form

Written

Electronic

S85:

palovarotene

No

OPA

Must be treated by, or in consultation with:

  • specialist medical practitioner experienced in the diagnosis and management of FOP

Yes - delayed assessment

Flare-up (acute) treatment

Streamlined

S85:

palovarotene

No

N/A

Must be treated by, or in consultation with:

  • specialist medical practitioner experienced in the diagnosis and management of FOP

N/A